Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 17, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 March 2026 - 16:02

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 17, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/kadcyla

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters